Circulating Plasma Cell-free DNA (cfDNA) as a Predictive Biomarker for Radiotherapy: Results from a Prospective Trial in Head and Neck Cancer.

Koukourakis, Michael I; Xanthopoulou, Erasmia; Koukourakis, Ioannis M; Fortis, Sotirios P; Kesesidis, Nikolaos; Karakasiliotis, Ioannis; Baxevanis, Constantin N

Koukourakis, Michael I; Xanthopoulou, Erasmia; Koukourakis, Ioannis M; Fortis, Sotirios P; Kesesidis, Nikolaos; Karakasiliotis, Ioannis; Baxevanis, Constantin N.

Afiliação

Koukourakis MI; Department of Radiotherapy - Oncology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Xanthopoulou E; Department of Radiotherapy - Oncology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Koukourakis IM; Radiation Oncology Unit, 1st Department of Radiology, Aretaieion University Hospital, Athens, Greece.
Fortis SP; Cancer Immunology and Immunotherapy Center, Cancer Research Center, Saint Savas Cancer Hospital, Athens, Greece.
Kesesidis N; Laboratory of Biology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Karakasiliotis I; Laboratory of Biology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.
Baxevanis CN; Cancer Immunology and Immunotherapy Center, Cancer Research Center, Saint Savas Cancer Hospital, Athens, Greece.

Cancer Diagn Progn ; 3(5): 551-557, 2023.

Article em En | MEDLINE | ID: mdl-37671311

Palavras-chave

Cell-free DNA; head neck cancer; prognosis; radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google